期刊文献+

雄激素性秃发患者血清二氢睾酮水平与非那雄胺治疗疗效的关系

Reduction in peripheral blood dihydrotestosterone is not correlated with efficacy of finasteride therapy in patients with androgenetic alopecia
下载PDF
导出
摘要 目的:探讨雄激素性秃发患者外周血二氢睾酮(DHT)、睾酮(T)与非那雄胺治疗疗效的关系。方法:把121例男性雄激素性秃发分成外周血DHT升高组(A组)64例和DHT正常组(B组)57例,分析其临床表现的特点,并将两组患者对非那雄胺治疗疗效积分的差异和DHT、T的变化,以及性勃起功能与DHT的关系进行对比观察。结果:A组患者平均年龄为(25.64±4.25)岁,B组患者平均年龄为(29.38±6.35)岁,A组患者的年龄和发病年龄比B组早,两组患者伴发家族史、病情严重程度无差异、对非那雄胺治疗的疗效、起效时间无差异。A组DHT水平与年龄、病情严重程度呈负相关;两组DHT下降与疗效积分无关,T升高亦与疗效积分无关;DHT的下降与勃起功能障碍相关。结论:雄激素性秃发患者外周血DHT越高,发病年龄越早;对非那雄胺治疗的疗效与外周血DHT水平无关,随着其疗效的提高外周血DHT会出现下降的趋势,但与下降的幅度无关:勃起功能障碍与外周血DHT下降有关。 Objective: To explore the correlation between the serum testosterone & dihydrotestosterone (DHT), testosterone (T) and finasteride therapy among patients with androgenetic alopecia (AGA). Methods: Divide 121 males with androgenetic alopecia into two groups as Increased Peripheral Blood DHT Group (Group A) of 64 males and Normal DHT Group (Group B) of 57 males, to analyze the clinical features, compare and observe the distinction of efficacy on finasteride therapy, the variation in DHT & T and the correlation of sexual erection and DHT. Results: The average age of Group A was 25.64±4.25, and Group B 29.38±6.35. The age and onset age of Group A were younger than Group B, but it was found no differ ence between the two groups on familial history, disease severity, efficacy of finasteride therapy and time to start to effect. For Group A, DHT level was negatively correlated with age and disease severity, but for the two groups, DHT reduction had no relation with the clinical efficacy and the total score, and the same for DHT increase, while DHT reduction had relation with erectile dysfunction. Conclusion: For the andorgenetic alopecia patients, the higher peripheral blood DHT, the younger onset age. And the efficacy of finasteride therapy is not correlated with peripheral blood DHT, but DHT will incline to decline as the efficacy of finasteride therapy increases, yet there is no relation between the efficacy of finasteride therapy and DHT reduction range. And the erectile dysfunction is correlated with reduction in peripheral blood DHT.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2012年第4期199-202,共4页 Journal of Clinical Dermatology
关键词 秃发 雄激素性 二氢睾酮 androgenetic alopecia dihydrotestosterone
  • 相关文献

参考文献7

  • 1王婷琳,沈佚葳,周城,王晓燕,丁晓岚,田珊,刘盈,彭光辉,薛树旗,周俊娥,王仁利,孟雪梅,裴广德,白云花,刘青,李航,陈捷,蔡林,张建中.我国6省雄激素性秃发流行病学调查[J].临床皮肤科杂志,2010,39(12):743-746. 被引量:23
  • 2王羿婷,李子海,尹晓晴,储小燕,李中明,许文荣,吴瑾,陈蕾,关宁宁,李磊磊,孙蔚凌,范卫新.非那雄胺和米诺地尔治疗雄激素性秃发的临床研究[J].临床皮肤科杂志,2011,40(7):387-390. 被引量:15
  • 3Camacho FM, Garca-Hernandez M J, Fernandez-Crehuet JL. Value of hormonal levels in patients with male androgenetic alopeeia treated with finasteride: better response in patients un- der 26 years old [J]. British Journal of Dermatology, 2008, 158: 1121-1124.
  • 4Ryu HK, Kim KM, Yoo EA. Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration [J]. British Journal of Dermatology, 2006, 154: 730-734.
  • 5Hugo Perez BS. Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men[J]. Medical Hypothe- ses, 2004, 62: 112-115.
  • 6Rodney Sinclair. Male pattern androgenic alopecia[J]. BMJ, 1998, 317(7162): 865-869.
  • 7Marquis P, Marrel A. Reproducibility and clinical and concur- rent validity of the MSF-4: a four-item male sexual function questionnaire for patients with benign prostatic hyperplasia[J]. Value Health, 2001, 4(4): 335-343.

二级参考文献27

  • 1陈声利,孙建方.米诺地尔治疗脱发的药理与临床研究[J].国外医学(皮肤性病学分册),2004,30(5):276-278. 被引量:59
  • 2Hamilton JB.Patterned loss of hair in man:types and incidence[J].Ann NY Acad Sci,1951,53:708-728.
  • 3Ludwig E.Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex[J].Br J Dermatol,1977,97(3):247-254.
  • 4Birch MP,Messenger JF,Messenger AG.Hair density,hair diameter and the prevalence of female pattern hair loss[J].Br J Dermatol,2001,144(2):297-304.
  • 5Norwood OT.Incidence of female androgenetic alopocia (female pattern alopecia)[J].Dermatol Surg,2001,27(1):53-54.
  • 6Rhodes T,Girman CJ,Savin RC,et al.Prevalence of male pattern hair loss in 18-49 year old men[J].Dermatol Surg,1998,24(12):1330-1332.
  • 7Severi G,Sinclair R,Hopper JL,et al.Androgenetie alopeciain men aged 40-69 years:prevalence and risk factors[J].Br J Dermatol,2003,149(6):1207-1213.
  • 8DeMuro-Mercon C,Rhodes T,Girman CJ,et al.Mah-pattern hair loss in Norwegian men:a community-based study[J].Dermatology,2000,200(3):219-222.
  • 9Desmond CC,Gan DC,Sinclair RD.Prevalence of male and female pattern hair loss in Maryborough[J].J Investig Dermatol Symp Proc,2005,10(3):184-189.
  • 10Khumalo NP,Jessop S,Gumedze F,et al.Hairdressing and the prevalence of scalp disease in African adults[J].Br J Dermatol,2007,157(5):981-988.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部